ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0948

Presentation of Apoptotic Cell-Derived Autoantigens in Systemic Autoimmune Disease

Lance Peterson1, Hannah KL De Cleene2, Cheryl Lichti2, David Bending3 and Kodi Ravichandran2, 1Rheumatology and Immunology, Pediatrics, Washington University School of Medicine, St. Louis, MO, 2Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, England, United Kingdom

Meeting: ACR Convergence 2025

Keywords: Apoptosis, autoantigens, Cell Death, Dendritic cells, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0934–0954) Systemic Lupus Erythematosus – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus is a chronic, multisystem autoimmune disease characterized by the dysregulated clearance of dying cells, which results in the release of damage-associated molecular patterns and intracellular targets of disease-associated autoantibodies. Dendritic cells are important mediators of ‘efferocytosis’ (the phagocytosis of apoptotic cells) and present apoptotic cell-derived autoantigens to CD4+ T cells via endocytic processing and MHC class II binding. Despite autoreactive T cells being essential to the pathogenesis and progression of diverse autoimmune diseases, there is only a nascent understanding of their autoantigen specificities. Prior studies have utilized almost exclusively model antigen systems (e.g. ovalbumin), without focus on cell death- and other inflammation-associated endogenous autoantigens.

Methods: We have developed and validated a mass spectrometry-based approach to characterize apoptotic cell-derived peptide autoantigens presented by dendritic cells (the ‘efferocytic immunopeptidome’). Furthermore, we have developed a novel approach for testing T cell antigen recognition, using TCR-dependent expression of a fluorescent timer protein, that operates independently of cytokine production, proliferation or effector function. This approach will be used to define populations of autoreactive T cells during homeostasis and in multiple mouse models of lupus.

Results: Our mass spectrometry studies have identified unique subcellular pools of antigens presented in the efferocytic immunopeptidome, including those of nuclear and ribosomal origin. Through our studies on T cell autoreactivity, we identify a small population of T cells from naïve and diseased mice that are reactive against the efferocytic immunopeptidome.

Conclusion: Efferocytosis promotes the presentation of unique pools of cellular peptide antigens that represent a potential source of autoantigen and the driving of autoreactive T cell modulation of diverse immune pathology. We hypothesize that T cell autoreactivity against apoptotic cell-derived antigens will be associated with pathogenic loss of tolerance or protective regulatory responses during disease.


Disclosures: L. Peterson: None; H. De Cleene: None; C. Lichti: None; D. Bending: None; K. Ravichandran: None.

To cite this abstract in AMA style:

Peterson L, De Cleene H, Lichti C, Bending D, Ravichandran K. Presentation of Apoptotic Cell-Derived Autoantigens in Systemic Autoimmune Disease [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/presentation-of-apoptotic-cell-derived-autoantigens-in-systemic-autoimmune-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presentation-of-apoptotic-cell-derived-autoantigens-in-systemic-autoimmune-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology